Historical record - last NADAC publication: 2/17/2021
Product Information
BUPROPION HCL SR 150 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1149 per EA under NDC 69097087812. Its NADAC has been published 233 times since Sep 14, 2016.
Strength
150 mg/1
Manufacturer
Cipla USA Inc.NDC
69097087812
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
2/17/2021
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206674On Market Since
7/25/2016
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL SR 150 MG TABLET has been published 233 times since Sep 14, 2016, and over the history we have for it it has declined 28.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1149 per EA |
|---|---|
| All-time high | $0.1653 (Oct 12, 2016) |
| All-time low | $0.1087 (Sep 23, 2020) |
| Median price | $0.1216 |
| Average price | $0.1297 |
| Largest weekly change | -10.1% (Apr 18, 2018) |
| Weeks tracked | 233 |
| Tracking since | Sep 14, 2016 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPROPION HCL SR 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 150 MG TABLET, manufactured by Cipla USA Inc., is $0.1149 per EA (NDC 69097087812), effective Feb 24, 2021.
How has the price of BUPROPION HCL SR 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL SR 150 MG TABLET has declined 28.6%. It has been tracked across 233 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 150 MG TABLET?
Since Sep 14, 2016, the NADAC for BUPROPION HCL SR 150 MG TABLET has ranged from a low of $0.1087 (Sep 23, 2020) to a high of $0.1653 (Oct 12, 2016), with a median of $0.1216 per EA.
Are there cheaper alternatives to BUPROPION HCL SR 150 MG TABLET?
Yes. 11 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0779 per EA — about 32% below BUPROPION HCL SR 150 MG TABLET.
Who manufactures BUPROPION HCL SR 150 MG TABLET?
BUPROPION HCL SR 150 MG TABLET (NDC 69097087812) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification